Leidos Holdings, Inc. (LDOS:NYE) has received a “Buy” rating from nine analysts covering the company, according to Stock Target Advisor. Of the analysts, four have rated Leidos stock as a Hold, while the remaining four have issued a buy recommendation. The average 12-month price target for Leidos stock, as estimated by brokerages that have covered it over the last year, is $114.29.
Leidos Stock Price Analysis:
LDOS has recently been the subject of various analyst reports, with several downgrading their price targets for the company. Despite this, Leidos stock opened at $92.31 on Thursday, down 1% from the previous day’s close.
The company’s 50-day moving average is $97.81, and its 200-day moving average is $99.18. Its market capitalization is $12.64 billion, and it has a P/E ratio of 18.69, a price-to-earnings-growth ratio of 1.77, and a beta of 0.76.
Quarterly Earnings Review:
On February 14th, LDOS announced its quarterly earnings, with earnings per share of $1.83, beating analysts’ consensus estimates by $0.22. The company had revenue of $3.70 billion, up 5.9% from the same quarter last year. Leidos had a net margin of 4.76% and a return on equity of 22.01%.
Leidos Stock Dividend:
LDOS also recently announced a quarterly dividend to be paid on March 31st. Shareholders of record on March 15th will receive a dividend of $0.36 per share. This represents an annualized dividend of $1.44 and a yield of 1.56%. The company’s dividend payout ratio is currently 29.15%.
Hedge Funds & Institutional Investors:
Several institutional investors have bought and sold Leidos stock shares recently, including Bessemer Group Inc., Versor Investments LP, Healthcare of Ontario Pension Plan Trust Fund, Edmond DE Rothschild Holding S.A., and Millennium Management LLC. These investors now own a total of 75.74% of the LDOS stock.
Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health.